Vitiligo

>

The HCPLive Vitiligo condition center page is a comprehensive resource for clinical news and insights on the dermatologic condition. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for the affected skin of vitiligo patients.

Latest News

Oral Povorcitinib for Extensive Nonsegmental Vitiligo Yields Positive Results in Phase 2b Trial
Oral Povorcitinib for Extensive Nonsegmental Vitiligo Yields Positive Results in Phase 2b Trial

October 11th 2023

This new data from the phase 2b trial on povorcitinib could lead to developments in the dermatology space for vitiligo patients.

Global Mental Health Burden for Vitiligo Greatest Among Darker Skin Types, Those with Facial or Hand Lesions
Global Mental Health Burden for Vitiligo Greatest Among Darker Skin Types, Those with Facial or Hand Lesions

September 3rd 2023

More than Skin Deep: Unmet Needs of Patients with Skin of Color
More than Skin Deep: Unmet Needs of Patients with Skin of Color

July 12th 2023

Oral Povorcitinib Significantly Improves Total, Facial Vitiligo in 24 Week Trial
Oral Povorcitinib Significantly Improves Total, Facial Vitiligo in 24 Week Trial

March 22nd 2023

Extension Study Showed Continued Strong Results for Ruxolitinib in Vitiligo Patients
Extension Study Showed Continued Strong Results for Ruxolitinib in Vitiligo Patients

March 18th 2023

Video Interviews
Podcasts
What Ruxolitinib Cream Meant For Dermatology in 2022
Seemal Desai, MD, FAAD

More News

© 2023 MJH Life Sciences

All rights reserved.